Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
February 28, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Conditions
Diabetes Mellitus, Insulin-Dependent, 1
Interventions
DRUG
Oshadi Icp
Trial Locations (1)
Unknown
Assaf-Harofeh Medical Center, Ẕerifin
All Listed Sponsors
lead
Oshadi Drug Administration
INDUSTRY
NCT01772251 - Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study | Biotech Hunter | Biotech Hunter